Implementing a Rehabilitation Program in Patients Recovering From Covid-19 Infection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-21

Study Completion Date

2022-02-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Implementation of a supervised rehabilitation program in patients recovering from COVID-19-infection who suffer from limitations and symptoms due to the disease 6 to 8 weeks from hospital discharge. Patients who have been seriously ill and have been admitted to the ward with high oxygen mixtures or have been admitted to the ICU will be selected primarily. The program includes supervised rehabilitation sessions 2 times a week for 2 months. Patients will be evaluated during recruitment and at the end of the program. Patients who can not attend the program due to logistical/transport issues will be re-evaluated in 2 months and constitute the control population. Investigators hypothesis is that post COVID-19 patients who have persistent symptoms, including fatigue following a supervised rehabilitation program will have fewer symptoms after the end of the program compared to similar patients who do not attend a rehabilitation program.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care

NCT04456036

COVID-19

UNKNOWN

Symptom-based Rehabilitation Compared to Usual Care in Post-COVID - a Randomized Controlled Trial

NCT05172206

COVID-19 Long-COVID

COMPLETED NA

Rehabilitation Program for the Sequelae of COVID 19 Infection

NCT04852718

Covid19

UNKNOWN

Implementation of Rehabilitation Program for Post COVID-19

NCT04694768

Post COVID-19 Syndrome Rehabilitation

UNKNOWN

Rehabilitation for People With COVID-19 in ICU

NCT04381338

Corona Virus Disease 19 (COVID-19) COVID Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Before and after trial matched cohort trial.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

The patients in this arm will be enrolled in a 2 months supervised rehabilitation program. Evaluation will take place at recruitment time and at the end of the program (2 months).

Group Type ACTIVE_COMPARATOR

Supervised rehabilitation program.

Intervention Type OTHER

The program includes aerobic exercise, strengthening exercises, physiotherapy, psychological support and dietary advice.

Control

The patients in this arm will not be enrolled in a supervised rehabilitation program. Evaluation will take place at recruitment and at 2 months.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supervised rehabilitation program.

The program includes aerobic exercise, strengthening exercises, physiotherapy, psychological support and dietary advice.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients recovering from COVID-19 disease AND suffering from persistent limitations (\>=1 month) of their physical activity and reduction of their quality of life and associated symptoms including shortness of breath, fatigue, weakness of the upper and lower extremities, post-traumatic stress, pain, etc.
* Priority will be given to patients suffering from more symptoms and disabilities. Patients who might suffer more after COVID-19 disease are:

1. Patients admitted to the ICU, especially those who were intubated.
2. Patients who needed high oxygen mixtures (high-flow nasal cannula -HFNC, non-re-breathing mask) as well as those who were older and had prolonged hospitalization.

\-

Exclusion Criteria

* Patients who suffer from active disease will not be included until they stop being infectious.
* Patients treated with COVID-19 infection where the main reason for hospitalization was not the virus infection (e.g. due to coronary heart disease, surgery, etc.) will also be excluded.
* Patients suffering from dementia,
* patients with myocarditis
* patients with thromboembolic disease that receive anticoagulants for less than a month
* patients chronically paralyzed,
* patients with paraplegia,
* patients with multiple injuries
* patients with serious orthopedic problems that cause disability
* patients suffering from very serious underlying diseases such as end-stage cancer,
* patients with neurological diseases that cause disability, require rehabilitation clinics and special interventions (speech therapy, kinesiotherapy, patients with tracheostomy etc.).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No